Skip to main content
Article thumbnail
Location of Repository

Proteomic Comparison of Entamoeba histolytica and Entamoeba dispar and the Role of E. histolytica Alcohol Dehydrogenase 3 in Virulence

By Paul H. Davis, Minghe Chen, Xiaochun Zhang, C. Graham Clark, R. Reid Townsend and Samuel L. Stanley


The protozoan intestinal parasite Entamoeba histolytica infects millions of people worldwide and is capable of causing amebic dysentery and amebic liver abscess. The closely related species Entamoeba dispar colonizes many more individuals, but this organism does not induce disease. To identify molecular differences between these two organisms that may account for their differential ability to cause disease in humans, we used two-dimensional gel-based (DIGE) proteomic analysis to compare whole cell lysates of E. histolytica and E. dispar. We observed 141 spots expressed at a substantially (>5-fold) higher level in E. histolytica HM-1∶IMSS than E. dispar and 189 spots showing the opposite pattern. Strikingly, 3 of 4 proteins consistently identified as different at a greater than 5-fold level between E. histolytica HM-1∶IMSS and E. dispar were identical to proteins recently identified as differentially expressed between E. histolytica HM-1∶IMSS and the reduced virulence strain E. histolytica Rahman. One of these was E. histolytica alcohol dehydrogenase 3 (EhADH3). We found that E. histolytica possesses a higher level of NADP-dependent alcohol dehydrogenase activity than E. dispar and that some EhADH3 can be localized to the surface of E. histolytica. Episomal overexpression of EhADH3 in E. histolytica trophozoites resulted in only subtle phenotypic differences in E. histolytica virulence in animal models of amebic colitis and amebic liver abscess, making it difficult to directly link EhADH3 levels to virulence differences between E. histolytica and less-pathogenic Entamoeba

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2004). A proteomic approach for the discovery of protease substrates.
  2. (1993). A redescription of Entamoeba histolytica Schaudinn,
  3. (1992). A severe combined immunodeficient (SCID) mouse model for infection with Entamoeba histolytica.
  4. (2006). Accurate mass-driven analysis for the characterization of protein phosphorylation. Study of the human Chk2 protein kinase.
  5. (2005). An unusual surface peroxiredoxin protects invasive Entamoeba histolytica from oxidant attack.
  6. (1999). Antisense inhibition of amoebapore expression in Entamoeba histolytica causes a decrease in amoebic virulence.
  7. (1992). Cloning and expression of an NADP +-dependent alcohol dehydrogenase gene of Entamoeba histolytica.
  8. (2006). Comparative proteomic analysis of two Entamoeba histolytica strains with different virulence phenotypes identifies peroxiredoxin as an important component of amoebic virulence.
  9. (2006). Comparative two-dimensional gel electrophoresis maps for promastigotes of Leishmania amazonensis and Leishmania major.
  10. (2006). Comparison of the proteome profiles of Entamoeba histolytica and its close but non-pathogenic relative Entamoeba dispar.
  11. (2002). Differential gene expression in Entamoeba histolytica isolated from amoebic liver abscess.
  12. (2008). Entamoeba dispar sequencing project.
  13. (1996). Entamoeba histolytica and Entamoeba dispar: differences in numbers and expression of cysteine proteinase genes.
  14. (2000). Entamoeba histolytica cysteine proteinases with interleukin-1 beta converting enzyme (ICE) activity cause intestinal inflammation and tissue damage in amoebiasis.
  15. (1994). Entamoeba histolytica has an alcohol dehydrogenase homologous to the multifunctional adhE gene product of Escherichia coli.
  16. (1998). Epithelial cell-initiated inflammation plays a crucial role in early tissue damage in amebic infection of human intestine.
  17. (2002). Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system.
  18. (1997). Human intestinal epithelial cells produce pro-inflammatory cytokines in response to infection in a SCID mouse-human intestinal xenograft model of amebiasis.
  19. (2006). Increased expression of the major cysteine proteinases by stable episomal transfection underlines the important role of EhCP5 for the pathogenicity of Entamoeba histolytica.
  20. (2002). Methods for cultivation of luminal parasitic protists of clinical importance.
  21. (1999). Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase.
  22. (1992). Oxido-reductive functions of Entamoeba histolytica in relation to virulence.
  23. Petricoin EF III (2004) Proteomics to diagnose human tumors and provide prognostic information.
  24. (2006). Pneumococcal 6-phosphogluconate-dehydrogenase, a putative adhesin, induces protective immune response in mice.
  25. (1994). Purification and molecular characterization of the NAD +- dependent acetaldehyde/alcohol dehydrogenase from Entamoeba histolytica.
  26. (2003). Shevchenko A
  27. (2001). The bifunctional Entamoeba histolytica alcohol dehydrogenase 2 (EhADH2) protein is necessary for amebic growth and survival and requires an intact C-terminal domain for both alcohol dehydrogenase and acetaldehyde dehydrogenase activity.
  28. (2002). The bittersweet interface of parasite and host: lectin-carbohydrate interactions during human invasion by the parasite Entamoeba histolytica.
  29. (2004). The LIM domain: from the cytoskeleton to the nucleus.
  30. (1995). Transfection and continuous expression of heterologous genes in the protozoan parasite Entamoeba histolytica.
  31. (2000). Two novel calcium-binding proteins from cytoplasmic granules of the protozoan parasite Entamoeba histolytica.
  32. (1988). Use of Chinese hamster ovary cells with altered glycosylation patterns to define the carbohydrate specificity of Entamoeba histolytica adhesion.
  33. (2002). Use of matrix clusters and trypsin autolysis fragments as mass calibrants in matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry.
  34. (2001). Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.